Please assess the completion status of the following clinical trial:

Trial Title: Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 18 years or above~2. Body mass index (BMI) of 35 or greater at the time of the first obstetric clinic visit~3. Undergoing cesarean delivery~Exclusion Criteria:~1. BMI less than 35.~2. Not undergoing Cesarean delivery.~3. Age less than 18 years.~4. Pre-existing infection.~5. Allergy to cephalosporin medications or a history of an anaphylactic reaction to penicillin.~6. Cesarean delivery being performed under emergent circumstances.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 2 gram dose of cefazolin (Type: ACTIVE_COMPARATOR): 2 gram dose of pre-operative cefazolin
- 4 gram Dose (Type: EXPERIMENTAL): 4 gram dose of pre-operative prophylaxis

Based on this trial design, predict the completion outcome and termination type (if applicable).